PMID- 28138653
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201001
IS  - 2415-1289 (Print)
IS  - 2415-1289 (Electronic)
IS  - 2415-1289 (Linking)
VI  - 1
DP  - 2016
TI  - Type 2 gastric neuroendocrine tumor: report of one case.
PG  - 88
LID - 10.21037/tgh.2016.11.05 [doi]
LID - 88
AB  - In this article we reported a female patient with type 2 gastric neuroendocrine 
      tumor (NET). The patient developed upper abdominal pain, acid reflux, heartburn, 
      nausea, and vomiting without obvious cause 16 years ago. Later, a tumor was found 
      in her stomach. Two years ago, a solid mass was found at the pancreatic head. 
      Somatostatin receptor scintigraphy showed positive result. Puncture biopsy showed 
      the presence of a NET. The serum gastrin level was significantly increased (3,527 
      pg/mL) at presentation. A second gastroscopy showed polypoid uplifts in gastric 
      body. Puncture biopsy confirmed the presence of a G2 NET in gastric body. The 
      patient previously had received a pituitary tumor surgery and thyroid gland 
      resection. The diagnosis was multiple endocrine neoplasia type 1 (MEN-1). The 
      treatments included sutent, lanreotide, and traditional Chinese herbs. In this 
      article we described the diagnosis and treatment of a patient with MEN-1 
      accompanied with type 2 gastric NET, which may be clinically informative.
FAU - Li, Yuanliang
AU  - Li Y
AD  - Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing 
      100029, China.
FAU - Su, Xin
AU  - Su X
AD  - Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing 
      100029, China.
FAU - Tan, Huangying
AU  - Tan H
AD  - Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing 
      100029, China.
LA  - eng
PT  - Case Reports
DEP - 20161130
PL  - China
TA  - Transl Gastroenterol Hepatol
JT  - Translational gastroenterology and hepatology
JID - 101683450
PMC - PMC5244809
OTO - NOTNLM
OT  - Gastric neuroendocrine neoplasm
OT  - gastrinoma
OT  - multiple endocrine neoplasia type 1 (MEN-1)
COIS- The authors have no conflicts of interest to declare.
EDAT- 2017/02/01 06:00
MHDA- 2017/02/01 06:01
PMCR- 2016/11/30
CRDT- 2017/02/01 06:00
PHST- 2016/10/27 00:00 [received]
PHST- 2016/11/10 00:00 [accepted]
PHST- 2017/02/01 06:00 [entrez]
PHST- 2017/02/01 06:00 [pubmed]
PHST- 2017/02/01 06:01 [medline]
PHST- 2016/11/30 00:00 [pmc-release]
AID - tgh-01-2016.11.05 [pii]
AID - 10.21037/tgh.2016.11.05 [doi]
PST - epublish
SO  - Transl Gastroenterol Hepatol. 2016 Nov 30;1:88. doi: 10.21037/tgh.2016.11.05. 
      eCollection 2016.